CXCL10 and Guillain-Barre syndrome: In addition, in the DENV/CHIKV neuroinvasive group, we found in 8 (encephalitis (6), myelitis (1), and another polyneuropathy (1)) of the 12 patients (66.7%) a CSF neopterin concentration higher than 11.23 nmol/L and in 11 (encephalitis (7), myelitis (1), NMOSD (1), GBS (1), and another polyneuropathy (1)) (92%) patients of this group we identified a CSF CXCL-10 concentration higher than 156.5 pg/mL.